Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease

doi:10.4239/wjd.v12.i12.2119

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3873)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

258

WORD

HTML

1949

Tables (1-5)

125

Sum=2425

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

1096

Sum=1448

Dec 15, 2021 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Dec 15, 2021; 12(12): 2119-2129
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.2119

Table 1 Characteristics of male participants according to appendicular skeletal muscle mass (%) quartiles, n (%)

Male	Quartiles of ASM%				P value	Female	Quartiles of ASM%				P value
	Q1	Q2	Q3	Q4			Q1	Q2	Q3	Q4
	n = 343	n = 343	n = 343	n = 342			n = 649	n = 651	n = 649	n = 650
Age (yr)	61.6 ± 8.8	63.2 ± 8.9^a	63.2 ± 8.9^a	69.4 ± 10.1^a	< 0.001	Age, yr	60.8 ± 8.7	61.7 ± 8.8^a	62.9 ± 9.4^a	64.8 ± 9.7^a	< 0.001
BMI (kg/m²)	22.7 ± 2.9	24.3 ± 3.4^a	24.3 ± 3.4^a	25.6 ± 2.9^a	< 0.001	Weight, kg	55.1 ± 8.1	58.0 ± 8.3^a	59.8 ± 8.6^a	62.6 ± 9.7^a	< 0.001
WC, cm	80.6 ± 9.1	85.8 ± 7.7^a	85.8 ± 7.7^a	91.7 ± 8.5^a	< 0.001	BMI, kg/m²	22.0 ± 2.7	23.5 ± 2.9^a	24.4 ± 3.1^a	26.0 ± 3.7^a	< 0.001
FM, kg	17.9 ± 4.6	20.3 ± 4.3^a	20.3 ± 4.3^a	24.5 ± 4.9^a	< 0.001	WC, cm	76.4 ± 7.9	80.5 ± 8.6^a	82.8 ± 8.5^a	87.5 ± 9.4^a	< 0.001
FM%	22.4 ± 4.2	27.2 ± 3.2^a	27.2 ± 3.2^a	33.1 ± 3.3^a	< 0.001	FM, kg	20.0 ± 4.1	22.5 ± 4.2^a	24.8 ± 4.8^a	27.6 ± 5.8^a	< 0.001
ASM%	32.6 ± 1.9	30.6 ± 1.0^a	30.6 ± 1.0^a	27.2 ± 1.6^a	< 0.001	FM%	32.2 ± 3.9	36.3 ± 2.9^a	38.8 ± 3.0^a	42.4 ± 3.4^a	< 0.001
SBP, mmHg	129 ± 18	134 ± 17^a	134 ± 17^a	141 ± 19^a	< 0.001	ASM%	27.7 ± 2.0	25.7 ± 0.8^a	24.5 ± 0.6^a	22.8 ± 1.1^a	< 0.001
DBP, mmHg	76 ± 11	78 ± 11^a	78 ± 11^a	77 ± 10	0.014	SBP, mmHg	129 ± 20	132 ± 19^a	135 ± 20^a	138 ± 19^a	< 0.001
FBG, mmol/L	5.4 ± 1.4	5.7 ± 1.7^a	5.7 ± 1.7^a	6.0 ± 1.7^a	< 0.001	DBP, mmHg	72 ± 10	74 ± 10^a	75 ± 9	76 ± 10^a	< 0.001
2hBG, mmol/L	6.7 ± 2.5	7.6 ± 2.9^a	7.6 ± 2.9^a	8.9 ± 3.7^a	< 0.001	FBG, mmol/L	5.3 ± 1.0	5.4 ± 1.2^a	5.5 ± 1.3^a	5.7 ± 1.7^a	< 0.001
HOMA-IR	1.2 (0.8-1.9)	1.8 (1.2-2.5)^a	1.8 (1.2-2.5)^a	2.5 (1.7-3.9)^a	< 0.001	2hBG, mmol/L	6.8 ± 2.6	7.2 ± 2.5^a	7.7 ± 4.0^a	8.3 ± 3.4^a	< 0.001
TG, mmol/L	1.2 (0.9-1.8)	1.4 (1.0-2.0)^a	1.4 (1.0-2.0)^a	1.6 (1.2-2.2)^a	< 0.001	HOMA-IR	1.6 (1.0-2.3)	1.8 (1.2-2.6)^a	2.1 (1.4-3.2)^a	2.3 (1.6-3.6)^a	< 0.001
TC, mmol/L	4.6 ± 0.8	4.7 ± 0.8^a	4.7 ± 0.8^a	4.7 ± 0.8^a	0.049	TG, mmol/L	1.2 (0.9-1.8)	1.4 (1.0-2.0)^a	1.5 (1.1-2.1)	1.6 (1.2-2.2)^a	< 0.001
HDL-C, mmol/L	1.40 ± 0.37	1.26 ± 0.29^a	1.26 ± 0.29^a	1.20 ± 0.25^a	< 0.001	TC, mmol/L	5.2 ± 0.8	5.3 ± 0.9	5.3 ± 0.9	5.4 ± 1.0^a	< 0.001
LDL-C, mmol/L	2.59 ± 0.72	2.75 ± 0.74	2.75 ± 0.74	2.72 ± 0.72^a	0.004	HDL-C, mmol/L	1.64 ± 0.42	1.54 ± 0.37^a	1.48 ± 0.34	1.46 ± 0.33^a	< 0.001
LFC%	3.9 (1.9-7.8)	5.0 (2.3-10.8)^a	5.0 (2.3-10.8)^a	6.3 (2.6-13.3)^a	< 0.001	LDL-C, mmol/L	2.86 ± 0.75	3.02 ± 0.79^a	3.04 ± 0.83^a	3.14 ± 0.86^a	< 0.001
NAFLD n (%)	68 (19.9)	107 (31.2)^a	107 (31.2)^a	141 (41.2)^a	< 0.001	LFC, %	4.8 (2.5-9.7)	5.8 (2.7-11.6)^a	5.9 (2.7-11.8)^a	7.1 (3.2-13.6)^a	< 0.001
DM n (%)	42 (12.3)	81 (23.6)^a	81 (23.6)^a	123 (35.8)^a	< 0.001	NAFLD n (%)	171 (26.3)	214 (32.9)^a	219 (33.7)^a	275 (42.3)^a	< 0.001
						DM n (%)	88 (13.6)	106 (16.3)	152 (23.4)^a	158 (24.3)^a	< 0.001

^aP < 0.05, compared with Q1. The quartiles of ASM% were divided as follows: Male, (Q1, ≥ 32.0%; Q2, ≥ 30.5%-32.0%; Q3, ≥ 29.0%-< 30.5%; Q4: < 29.0%) and female, (Q1, ≥ 26.8%; Q2, ≥ 25.5% -< 26.8%; Q3, ≥ 24.3%-< 25.5%; Q4, < 24.3%).

BMI: Body mass index; WC: Waist circumference; FM: Fat mass; ASM: Appendicular skeletal muscle mass; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; 2hBG: 2-h postprandial blood glucose; HOMA-IR: Homeostasis model assessment for insulin resistance; TG: Triglycerides; TC: Total cholesterol; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein cholesterol; LFC: Liver fat content; NAFLD: Non-alcoholic fatty liver disease; DM: Diabetes mellitus.

Table 2 Spearman analysis of appendicular skeletal muscle mass (%) and other clinical parameters

	ASM%
	Male (r, P value)	Female (r, P value)
Age (years)	-0.317, < 0.001	-0.164, < 0.001
BMI (kg/m²⁾	-0.347, < 0.001	-0.441, < 0.001
WC (cm)	-0.452, < 0.001	-0.448, < 0.001
FM (kg)	-0.605, < 0.001	-0.590, < 0.001
FM (%)	-0.792, < 0.001	-0.799, < 0.001
FBG (mmol/L)	-0.177, < 0.001	-0.106, < 0.001
2hBG (mmol/L)	-0.254, < 0.001	-0.201,< 0.001
HOMA-IR	-0.385, < 0.001	-0.264, < 0.001
TG (mmol/L)	-0.198, < 0.001	-0.193, < 0.001
TC (mmol/L)	-0.049, 0.071	-0.087, < 0.001
HDL-C (mmol/L)	0.213, < 0.001	0.162, < 0.001
LDL-C (mmol/L)	-0.075, 0.006	-0.119, < 0.001
SBP (mm Hg)	-0.244, < 0.001	-0.192, < 0.001
DBP (mm Hg)	-0.075, 0.006	-0.139, < 0.001
LFC (%)	-0.149, < 0.001	-0.113, < 0.001

ASM: Appendicular skeletal muscle mass; BMI: Body mass index; WC: Waist circumference; FM: Fat mass; FBG: Fasting blood glucose; 2hBG: 2-h postprandial blood glucose; HOMA-IR: Homeostasis model assessment for insulin resistance; TG: Triglycerides; TC: Total cholesterol; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein cholesterol; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; LFC: Liver fat content.

Table 3 Multivariate-adjusted associations of appendicular skeletal muscle mass (%) quartiles with diabetes mellitus

	Male	Female
	OR (95%CI, P value)	OR (95%CI, P value)
Unadjusted	0.665	0.775
Unadjusted	(0.592-0.746, < 0.001)	(0.710-0.847, < 0.001)
Model 1	0.527	0.505
Model 1	(0.336-0.826, 0.005)	(0.342-0.745, 0.001)
Model 2	0.640	0.728
Model 2	(0.401-1.020, 0.051)	(0.481-1.101, 0.133)
Model 3	0.537	0.985
Model 3	(0.312-0.923, 0.024)	(0.614-1.580, 0.950)

Model 1: Adjusted for age, cigarette smoking, diabetes family history, FM, and FM × ASM% quartiles, and obesity. Model 2: Adjusted for covariates in Model 1 plus SBP, TG, and HDL-C. Model 3: Adjusted for covariates in Model 3 plus HOMA-I. OR: Odds ratio; FM: fat mass; ASM: Appendicular skeletal muscle mass; SBP: Systolic blood pressure; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; HOMA-IR: Homeostasis model assessment for insulin resistance.

Table 4 Multivariate-adjusted associations of appendicular skeletal muscle mass (%) quartiles with diabetes mellitus in participants with or without non-alcoholic fatty liver disease

	Male	Female
	OR (95%CI, P value)	OR (95%CI, P value)
	Non-NAFLD (n = 2658)
Unadjusted	0.635	0.770
Unadjusted	(0.548-0.736, < 0.001)	(0.682-0.870, < 0.001)
Model 1	0.403	0.581
Model 1	(0.221-0.735, 0.003)	(0.344-0.981, 0.042)
Model 2	0.455	0.807
Model 2	(0.246-0.842, 0.012)	(0.463-1.409, 0.452)
Model 3	0.330	0.800
Model 3	(0.157-0.694, 0.003)	(0.416-1.537, 0.503)
	NAFLD (n = 1311)
Unadjusted	0.789	0.845
Unadjusted	(0.650-0.956, 0.016)	(0.739-0.966, 0.014)
Model 1	1.259	0.508
Model 1	(0.542-2.924, 0.592)	(0.265-0.975, 0.042)
Model 2	1.954	0.710
Model 2	(0.788-4.851, 0.148)	(0.355-1.418, 0.332)
Model 3	1.328	1.106
Model 3	(0.435-4.055, 0.619)	(0.485-2.523, 0.810)

Model 1: Adjusted for age, cigarette smoking, diabetes family history, FM, FM × ASM% quartiles, and obesity. Model 2: Adjusted for covariates in Model 1 plus SBP, TG, and HDL-C. Model 3: Adjusted for covariates in Model 3 plus HOMA-IR. OR: Odds ratio; FM: Fat mass; ASM: Appendicular skeletal muscle mass; SBP: Systolic blood pressure; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; HOMA-IR: Homeostasis model assessment for insulin resistance.

Table 5 Multivariate-adjusted associations of appendicular skeletal muscle mass (%) quartiles with diabetes mellitus in participants with different liver fat content, n (%)

LFC	DM	OR (95%CI, P value)	OR (95%CI, P value)
Male		Unadjusted	After adjusted
Q1 (n = 389)	82 (21.1)	0.635 (0.504-0.799, < 0.001)	0.308 (0.102-0.932, 0.032)
Q2 (n = 350)	66 (18.8)	0.540 (0.416-0.700, < 0.001)	0.184 (0.049-0.685, 0.012)
Q3 (n = 306)	74 (24.2)	0.760 (0.599-0.963, 0.023)	0.678 (0.158-2.908, 0.601)
Q4(n = 325)	116 (35.7)	0.830 (0.665-1.035, 0.099)	1.561 (0.440-5.539, 0.491)
Female
Q1 (n = 605)	84 (13.9)	0.828 (0.672-1.021, 0.077)	0.964 (0.311-2.990, 0.949)
Q2 (n = 642)	92 (14.3)	0.745 (0.609-0.913, 0.004)	0.517 (0.170-1.578, 0.247)
Q3 (n = 685)	118 (17.2)	0.739 (0.615-1.887, 0.091)	0.750 (0.274-2.048, 0.574)
Q4 (n = 667)	210 (31.5)	0.871 (0.750-1.011, 0.070)	1.122 (0.445-2.830, 0.808)

The quartiles of LFC were divided as follows: Q1: < 2.53%; Q2: ≥ 2.53%-< 5.52%; Q3: ≥ 5.52%- < 11.61%; Q4: ≥ 11.61%. Adjusted factors: Age, cigarette smoking, diabetes family history, FM, FM × ASM% quartiles, obesity, SBP, TG, HDL-C, and HOMA-IR. LFC: Liver fat content; DM: Diabetes mellitus; OR: Odds ratio; FM: Fat mass; ASM: Appendicular skeletal muscle mass; SBP: Systolic blood pressure; TG: Triglycerides; HDL-C: High-density lipoprotein-cholesterol; HOMA-IR: Homeostasis model assessment for insulin resistance.

Citation: Chen LY, Xia MF, Wu L, Li Q, Hu Y, Ma H, Gao X, Lin HD. Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease. World J Diabetes 2021; 12(12): 2119-2129
URL: https://www.wjgnet.com/1948-9358/full/v12/i12/2119.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i12.2119